What should I Know Regarding Pregnancy, Nursing and Administering Polatuzumab Vedotin-Piiq 140 Mg Intravenous Solution to Children or the Elderly?
If you are PREGNANT
- Not Recommended: BASED ON DRUG PHARMACOLOGY DEVELOPMENTAL TOXICITY IS POSSIBLE
If you are NURSING
- Absolute Contraindication: MANUFACTURER DOES NOT RECOMMEND DURING TX AND FOR 2 MO AFTER LAST DOSE
If you are an adult over 60
- management or monitoring precaution: General-Patients older than 64 years showed higher incidence of serious ADRs (neutropenia, thrombocytopenia, anemia, hypokalemia, pneumonia).
Giving Polatuzumab Vedotin-Piiq 140 Mg Intravenous Solution to a child under 12
- management or monitoring precaution: Safety and effectiveness have not been established in pediatric patients.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.